Dec 9 (Reuters) - CVS Health (CVS) on Tuesday forecast 2026 profit above Wall Street estimates and this year's projected earnings, signalling steady progress in the health conglomerate's turnaround plan.
CVS stock rose 5% in early trading on Tuesday.
The company in October projected double-digit earnings growth for 2026 after raising its 2025 profit forecast for the third time.
"We are closing out 2025 with meaningful momentum across our businesses and we expect another year of strong earnings growth in 2026," said Chief Financial Officer Brian Newman on Tuesday.
The company forecast 2026 adjusted profit to be in the range of $7.00 to $7.20 per share, compared with analysts' average estimate of $7.16, according to data compiled by LSEG.
It, however, expects total revenue of at least $400 billion next year, below analysts' average estimate of $419.26 billion.
CVS also raised its 2025 adjusted profit forecast to $6.60 to $6.70 per share from $6.55 to $6.65 previously.
(Reporting by Sneha S K in Bengaluru; Editing by Shinjini Ganguli)
LATEST POSTS
- 1
Figure out What Shift Differentials Mean for Your General Attendant Compensation - 2Favored Chinese Dish: Make Your Determination
- 3Israeli forces kill one person in series of attacks on southern Lebanon
- 4Deadly attack on kindergarten reported in Sudan
- 541 Young Men Die in South Africa After Circumcision Initiation
- Find the Advantages of Positive Nurturing: Supporting Cheerful and Sound Kids
- Figure out how to Perceive Warnings while Looking for an Auto Collision Lawyer
- EU chief urges Iran to free imprisoned protesters, lift internet ban
- From Overpowered to Coordinated: Individual Accounts of Cleaning up
- Step by step instructions to Safeguard Your Teeth During Sports Exercises
- Merck urges science-led US vaccine schedule after CDC trims childhood vaccine list
- Vote in favor of your #1 Kind of Cap
- The Force of Organic product: 10 Assortments That Improve Your Wellbeing
- This Week In Space podcast: Episode 189 — Privatizing Orbit
